HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer
September 08, 2024 20:00 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR
September 08, 2024 19:22 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lifecore Biomedical, Inc. (NASDAQ: LFCR) between October 7,...
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
September 08, 2024 19:10 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Sept. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative...
NOVONIX Announces Participation in the H.C. Wainwright Conference
September 08, 2024 18:55 ET
|
Novonix Ltd.
BRISBANE, Australia, Sept. 09, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today announced that the company is...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Five Below, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FIVE
September 08, 2024 18:19 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Five Below, Inc. (NASDAQ: FIVE) between March 20, 2024...
Ultimovacs Announces Updated Data Analysis on UV1 Phase II NIPU Trial in Mesothelioma at ESMO 2024
September 08, 2024 18:10 ET
|
Ultimovacs ASA
Oslo, September 9, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces the presentation of updated data...
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
September 08, 2024 18:05 ET
|
Avacta Group
8 September 2024 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress ...
C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
September 08, 2024 18:05 ET
|
C4 Therapeutics, Inc.
Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity Investor Webcast to be Held Friday, September 13, 2024 at 12:00 pm ET ...
Bitget introduce la opción de depósito en MXN a través de SPEI, con tecnología Swapple, para realizar compras de criptomonedas sin inconvenientes
September 08, 2024 17:27 ET
|
Bitget Limited
VICTORIA, Seychelles, Sept. 08, 2024 (GLOBE NEWSWIRE) -- Bitget, la principal bolsa de criptomonedas y empresa Web3, ha anunciado su asociación estratégica con Swapple para ofrecer soluciones de...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Stellantis N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STLA
September 08, 2024 17:23 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stellantis N.V. (NYSE: STLA) between February 15, 2024 and...
- September 08, 2024 17:00 ET SPEE3D SHOWCASES EXPEDITIONARY MANUFACTURING UNIT (EMU) FOR THE FIRST TIME IN AUSTRALIA AT LAND FORCES INTERNATIONAL EXPOSITION
- September 07, 2024 11:00 ET IFA 2024: JMGO Launches N1S Ultimate 4K and N1S Pro 4K with MALC™ 2.0 Triple Laser Optics, Pushing Boundaries in Laser Projection